Conduit / Parity

CDT Equity Inc. (formerly Conduit Pharmaceuticals) is a data-driven biopharmaceutical development company focused on identifying, enhancing, and advancing therapeutic assets through scientific innovation and strategic partnerships. It operates as a clinical-stage, disease-agnostic life science platform that acquires or licenses Phase II-ready assets and develops them toward licensing or other exit opportunities.